Bloomberg • 12/12/2025 • Last cited 12/14/2025
Novo Nordisk is launching Ozempic for type-2 diabetes in India with a pricing strategy tailored to the local market, according to Bloomberg. The company aims to make the medication more accessible to Indian patients while addressing the unique economic conditions in the region.